JAK JONES has pulled out of the English Open but he has a valid reason for the sudden withdrawal – his wife is due to give birth this week. The Welsh potter, 33, out-grinded the ultimate snooker ...

Bonnie Blue’s “breeding mission” saw about 400 sign-ups from men, including gay creator Jak White. “It seemed like a fun event,” White, 20, exclusively told Us Weekly on the heels of Blue, 26, ...

Patients with alopecia areata (AA) who do not respond to treatment with one of the three approved JAK inhibitors may get a response by switching to one of the other JAK inhibitors, a small study has ...

A meta-analysis showed no significant differences between JAK inhibitor use and TNF antagonist use in terms of the risk for serious infections or malignant neoplasms in patients with immune-mediated ...

Maddie is a Contributor at DualShockers covering JRPGs, survival horror, arcade games, retro gaming, shooters, and features. She has been writing about games professionally since 2011, with more than ...

Existing autoimmune drugs may prevent or reverse a serious side effect faced by patients with cancer. Immunotherapy-induced type 1 diabetes is a serious side effect faced by some patients receiving ...

Incyte pulled $4.2 billion in full-year 2024 product revenues. (SOPA Images/LightRocket/Getty Images) Incyte’s ruxolitinib franchise, made up of blockbuster JAK inhibitor Jakafi and its topical ...

Dalton Cooper is the Managing Editor of GameRant. Dalton has been writing about video games professionally since 2011 and joined the GameRant team in 2015. Having written thousands of game reviews and ...

JAK inhibitors like baricitinib, ritlecitinib, and brepocitinib show promise in treating alopecia areata, with baricitinib approved by FDA and EMA. Baricitinib significantly reduced SALT scores at 24 ...

Created by Masashi Kishimoto, Naruto is a beloved manga series that chronicles the journey of Naruto Uzumaki, a young ninja recognized by his peers and dreams of becoming the Hokage, the leader of his ...

James R. Berenson, MD, describes ongoing efforts to evaluate treatment with JAK inhibitors like ruxolitinib among patients with multiple myeloma. CancerNetwork ® spoke with James R. Berenson, MD, ...